E-viri
Recenzirano
Odprti dostop
-
Weinbrecht-Mischkewitz, Max; Kamal, Midhat; Asim, Farwa; Guillemin, Francis; Goel, Niti; Voshaar, Marieke; Boonen, Annelies; Berthelsen, Dorthe Bang; Toupin-April, Karine; Lopez-Olivo, Maria A.; Sloan, Victor S.; Boers, Maarten; Jones, C. Allyson; van der Horst-Bruinsma, Irene; Cashin, Aidan G.; Sharma, Saurab; Leong, Amye; Alten, Rieke; Shea, Beverley; March, Lyn; Tugwell, Peter; Christensen, Robin; Nielsen, Sabrina Mai
Seminars in arthritis and rheumatism, April 2024, 2024-Apr, 2024-04-00, 20240401, Letnik: 65Journal Article
To generate candidates for contextual factors (CFs) for each CF type (i.e., Effect Modifying Contextual Factors (EM-CFs), Outcome Influencing Contextual Factors (OI-CFs), and Measurement Affecting Contextual Factors (MA-CFs)) considered important within rheumatology. We surveyed OMERACT working groups and conducted a Special Interest Group (SIG) session at the OMERACT 2023 meeting, where the results were reviewed, and additional CFs suggested. The working groups suggested 44, 49, and 21 generic EM-CFs, OI-CFs, and MA-CFs, respectively. SIG participants added 49, 44, and 55 factors, respectively. Candidate CFs were identified, next step is a consensus-based set of endorsed (important) CFs.
